Development of new methods for the evaluation and protection of drug induced nephrotoxicity using kidney epithelial cell line (LLC-PK_1)

开发利用肾上皮细胞系(LLC-PK_1)评估和保护药物引起的肾毒性的新方法

基本信息

  • 批准号:
    63870108
  • 负责人:
  • 金额:
    $ 4.35万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
  • 财政年份:
    1988
  • 资助国家:
    日本
  • 起止时间:
    1988 至 1989
  • 项目状态:
    已结题

项目摘要

The kidney is a major organ for the excretion of xenobiotics, and is susceptible to drug-induced nephrotoxicity. We attempted to establish new methods for the evaluation and protection of nephrotoxicity of drugs by using a cultured kidney epithelial cell line, LLC-PK_1. Aminoglycoside antibiotics, cyclosporin (immunosuppressive agent), and cisplatin (antitumor agent) were employed in this study. These drugs are widely used clinically, but their use is sometimes complicated by acute nephrotoxicity.1. The effect of aminoglycoside, cyclosporin, and cisplatin was tested in LLC-PK_1 cells, and it was found that the number of viable cells, the number of floating cells (dead cells), the ability to form domes, and the activities of apical marker enzymes (aminopeptidase, alkaline phosphatase, and gamma-glutamyltransferase) are useful as markers of drug-induced cytotoxicity. There was a good relationship between the potencies of various aminoglycosides to inhibit apical enzymes in LLC-PK, cells … More and the nephrotoxic potencies of these drugs in vivo. In addition, aminoglycoside and cyclosporin induced the elevation of cytosolic free calcium concentration, which may be a important determinant of drug-induced nephrotoxicity.2. The inhibitory effect of gentamicin on the apical enzyme activities was dosedependent, and was related to its accumulation in the cells. Apparently, intracellular accumulation of cyclosporin was also related to its cytotoxicity, when judged by the level of cytosolic free calcium and the number of viable cells.3. Cytotoxicity of cisplatin was more potent on exponentially growing cells than on confluent cells. Glutathione attenuated the toxicity of cisplatin. In contrast, cyclosporin was toxic on growing and confluent cells, and glutathione had no effect on its cytotoxicity, indicating that biochemical mechanisms of nephrotoxicity are different among different drugs.In conclusion, cultured kidney epithelial cell line (LLC-PKi) should be a useful model system to evaluate the nephrotoxicity of drugs, and to develop a new method to protect the drug-induced nephrotoxicity. Less
肾脏是异生物质排泄的主要器官,容易受到药物引起的肾毒性的影响。我们尝试利用培养的肾上皮细胞系LLC-PK_1建立评估和保护药物肾毒性的新方法。本研究使用氨基糖苷类抗生素、环孢素(免疫抑制剂)和顺铂(抗肿瘤剂)。这些药物在临床上应用广泛,但有时会因急性肾毒性而使使用变得复杂。 1.在 LLC-PK_1 细胞中测试了氨基糖苷、环孢素和顺铂的作用,发现活细胞数、漂浮细胞(死细胞)数、形成圆顶的能力以及顶端标记酶(氨肽酶、碱性磷酸酶和 γ-谷氨酰转移酶)的活性可用作标记物 药物诱导的细胞毒性。各种氨基糖苷类抑制 LLC-PK、细胞中顶端酶的效力与这些药物在体内的肾毒性效力之间存在良好的关系。此外,氨基糖苷类和环孢素可引起胞质游离钙浓度升高,这可能是药物肾毒性的重要决定因素。 2.庆大霉素对顶端酶活性的抑制作用呈剂量依赖性,并与其在细胞内的蓄积有关。显然,从胞质游离钙水平和活细胞数来判断,环孢素在细胞内的积累也与其细胞毒性有关。 3.顺铂对指数生长细胞的细胞毒性比对汇合细胞的细胞毒性更强。谷胱甘肽减弱顺铂的毒性。相比之下,环孢素对生长和汇合的细胞有毒性,而谷胱甘肽对其细胞毒性没有影响,这表明不同药物的肾毒性生化机制不同。 总之,培养的肾上皮细胞系(LLC-PKi)应该是评估药物肾毒性的有用模型系统,并开发一种新的方法来保护肾毒性。 药物引起的肾毒性。较少的

项目成果

期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inui,ken-ichi: "Aminiglycoside-induced alterations in apical membranes of kidney epithelial cell line(LLC-PK_1)." Am.J.Physiol.254. C251-C257 (1988)
Inui,ken-ichi:“氨基糖苷诱导的肾上皮细胞系(LLC-PK_1)顶膜的改变。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Iwata,Toshio: "Effect of brain matriuretic peptide on cvclic GMP accumulation in a kidnev epithelial cell line(LLC-PK_1)." European J.Pharmacol.159. 321-323 (1989)
Iwata, Toshio:“脑泌尿肽对肾上皮细胞系 (LLC-PK_1) 循环 GMP 积累的影响。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Inui,Ken-ichi: "Decreased transport of p-aminohippurate in renal basolateral membranes isolated from rats with acute renal failure." Pharm.Res.6. 954-957 (1989)
Inui,Ken-ichi:“从急性肾功能衰竭大鼠中分离出的肾基底外侧膜中对氨基马尿酸的转运减少。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
堀了平: "薬物血中濃度モニタリングのためのPopulation Pharmacokinetics入門" 薬業時報社, 300 (1988)
Ryohei Hori:“监测血液药物浓度的群体药代动力学简介”Yakugyo Jihosha,300 (1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
堀了平: "生物学的利用能" ソフトサイエンス社, 333 (1988)
Ryohei Hori:“生物利用度”软科学出版,333(1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HORI Ryohei其他文献

HORI Ryohei的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HORI Ryohei', 18)}}的其他基金

Integrative studies on acclimatization mechanism to extreme altitude hypoxia in Himalayan areas - A joint project of Kyoto and Chida University
喜马拉雅地区极端高原缺氧适应机制综合研究——京都府与千田大学联合项目
  • 批准号:
    02041047
  • 财政年份:
    1992
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Scientific Basis of Drug Disposition in the Kidney and its Application to Clinical Dosage Regimens.
肾脏药物分布的科学基础及其在临床剂量方案中的应用。
  • 批准号:
    03454488
  • 财政年份:
    1991
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Pharmacokinetics and Pharmacodynamics of Antiarrhythmic Drugs in Disease State
抗心律失常药物疾病状态下的药代动力学和药效学
  • 批准号:
    62480431
  • 财政年份:
    1987
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Application of population pharmacokinetics to the individualization of drug dosage regimen.
群体药代动力学在个体化药物剂量方案中的应用。
  • 批准号:
    60870093
  • 财政年份:
    1985
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research

相似海外基金

Cost-Effective, AI-driven Automation Technology for Cell Culture Monitoring: Boosting Efficiency and Sustainability in Industrial Biomanufacturing and Streamlining Supply Chains
用于细胞培养监测的经济高效、人工智能驱动的自动化技术:提高工业生物制造的效率和可持续性并简化供应链
  • 批准号:
    10104748
  • 财政年份:
    2024
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Launchpad
I-Corps: Translation Potential of a Cell Culture Platform to Model Dynamic Drug Concentrations In Vitro
I-Corps:细胞培养平台模拟体外动态药物浓度的转化潜力
  • 批准号:
    2405765
  • 财政年份:
    2024
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Standard Grant
Unlocking the helminth ‘early infection gap’ using 3D cell culture models
使用 3D 细胞培养模型解锁蠕虫“早期感染间隙”
  • 批准号:
    DE240100295
  • 财政年份:
    2024
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Discovery Early Career Researcher Award
PeptiMatrix: Next generation peptide hydrogels for 3D cell culture
PeptiMatrix:用于 3D 细胞培养的下一代肽水凝胶
  • 批准号:
    10070302
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Collaborative R&D
Evaluation of novel microscale cell culture platform for translational drug development in prostate cancer
用于前列腺癌转化药物开发的新型微型细胞培养平台的评估
  • 批准号:
    10588604
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Evolutionary study of primate olfaction, taste and color-vision sensor genes by targeted capture and cell-culture-based functional assay
通过靶向捕获和基于细胞培养的功能测定对灵长类动物嗅觉、味觉和色觉传感器基因的进化研究
  • 批准号:
    23H02561
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of Spatiotemporal Controlled Bioluminescence in 3D Printed Plant Cell Culture Systems
3D 打印植物细胞培养系统中时空控制生物发光的发展
  • 批准号:
    23KF0253
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Primary cell culture models of HIV/HBV co-infection
HIV/HBV合并感染的原代细胞培养模型
  • 批准号:
    10762093
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Virus, Vector and Cell Culture Core
病毒、载体和细胞培养核心
  • 批准号:
    10714178
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Label-free volumetric microscopy for visualizing intracellular motility of tumor cell culture
用于可视化肿瘤细胞培养物细胞内运动的无标记体积显微镜
  • 批准号:
    22KF0058
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了